Gary Xu, Nicolás Urriola. Topical ruxolitinib for resistant dupilumab‐associated facial dermatitis. // Internal Medicine Journal. – 2026. – DOI: 10.1111/imj.70625. – URL: https://onlinelibrary.wiley.com/doi/10.1111/imj.70625?af=R
Gary Xu & Nicolás Urriola (2026). Topical ruxolitinib for resistant dupilumab‐associated facial dermatitis. Internal Medicine Journal. https://doi.org/10.1111/imj.70625
Gary Xu and Nicolás Urriola. “Topical ruxolitinib for resistant dupilumab‐associated facial dermatitis.” Internal Medicine Journal, 2026. doi:10.1111/imj.70625.
@article{Xu2026,
title = {Topical ruxolitinib for resistant dupilumab‐associated facial dermatitis},
author = {Xu, Gary and Urriola, Nicolás},
journal = {Internal Medicine Journal},
year = {2026},
doi = {10.1111/imj.70625},
url = {https://onlinelibrary.wiley.com/doi/10.1111/imj.70625?af=R}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...